<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>BRAIN BIOTECH RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Wed, 13 May 2026 12:05:54 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/brain%5Fbiotech%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>BRAIN BIOTECH RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>EQS-News: BRAIN Biotech erhält bedeutendes Patent für seine CRISPR-BMC Genome-Editing-Technologie</title><pubDate>Mon, 23 Mar 2026 11:05:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-brain-biotech-erh-lt-bedeutendes-patent-f-r-seine-crispr-bmc-genome-editing-technologie-15571244</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Schlagwort(e): Patent


<br/>


BRAIN Biotech erhält bedeutendes Patent für seine CRISPR-BMC Genome-Editing-Technologie <br/><br/>






23.03.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-brain-biotech-erh-lt-bedeutendes-patent-f-r-seine-crispr-bmc-genome-editing-technologie-15571244</guid></item><item><title>EQS-News: BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology</title><pubDate>Mon, 23 Mar 2026 11:05:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-brain-biotech-has-been-granted-a-key-patent-for-its-crispr-bmc-genome-editing-technology-15571248</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Key word(s): Patent


<br/>


BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology <br/><br/>






23.03.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-brain-biotech-has-been-granted-a-key-patent-for-its-crispr-bmc-genome-editing-technology-15571248</guid></item><item><title>EQS-News: Ergebnisse der Hauptversammlung 2026 zum Finanzjahr 2024/25 der BRAIN Biotech AG</title><pubDate>Wed, 11 Mar 2026 17:05:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-ergebnisse-der-hauptversammlung-2026-zum-finanzjahr-2024-25-der-brain-biotech-ag-15549859</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Schlagwort(e): Hauptversammlung


<br/>


Ergebnisse der Hauptversammlung 2026 zum Finanzjahr 2024/25 der BRAIN Biotech AG <br/><br/>






11.03.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-ergebnisse-der-hauptversammlung-2026-zum-finanzjahr-2024-25-der-brain-biotech-ag-15549859</guid></item><item><title>EQS-News: Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG</title><pubDate>Wed, 11 Mar 2026 17:05:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-results-of-the-2026-annual-general-meeting-for-the-2024-25-financial-year-of-brain-biotech-ag-15549860</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Key word(s): AGM/EGM


<br/>


Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG <br/><br/>






11.03.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-results-of-the-2026-annual-general-meeting-for-the-2024-25-financial-year-of-brain-biotech-ag-15549860</guid></item><item><title>EQS-News: FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control</title><pubDate>Wed, 14 Jan 2026 07:30:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-fy-2024-25-brain-biotech-ag-benefits-from-successful-monetization-of-projects-and-strong-corporate-cost-control-15413970</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Key word(s): Annual Report/Annual Results


<br/>


FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-fy-2024-25-brain-biotech-ag-benefits-from-successful-monetization-of-projects-and-strong-corporate-cost-control-15413970</guid></item><item><title>EQS-News: Geschäftsjahr 2024/25: BRAIN Biotech AG profitiert durch erfolgreiche Monetarisierung von Projekten und starker Kostenkontrolle</title><pubDate>Wed, 14 Jan 2026 07:30:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-gesch-ftsjahr-2024-25-brain-biotech-ag-profitiert-durch-erfolgreiche-monetarisierung-von-projekten-und-starker-kostenkontrolle-15413973</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Schlagwort(e): Jahresbericht/Jahresergebnis


<br/>


Geschäftsjahr 2024/25: BRAIN Biotech AG profitiert durch erfolgreiche Monetarisierung  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-gesch-ftsjahr-2024-25-brain-biotech-ag-profitiert-durch-erfolgreiche-monetarisierung-von-projekten-und-starker-kostenkontrolle-15413973</guid></item><item><title>EQS-AFR: BRAIN Biotech AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG</title><pubDate>Tue, 06 Jan 2026 11:59:23 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-afr-brain-biotech-ag-vorabbekanntmachung-ber-die-ver-ffentlichung-von-finanzberichten-gem-114-115-117-wphg-15394862</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS Vorabbekanntmachung Finanzberichte: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten


<br/>


BRAIN Biotech AG: Vorabbekanntmachung  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-afr-brain-biotech-ag-vorabbekanntmachung-ber-die-ver-ffentlichung-von-finanzberichten-gem-114-115-117-wphg-15394862</guid></item><item><title>EQS-AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]</title><pubDate>Tue, 06 Jan 2026 11:59:23 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-afr-brain-biotech-ag-preliminary-announcement-of-the-publication-of-financial-reports-according-to-articles-114-115-117-of-the-wphg-the-german-securities-act-15394863</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS Preliminary announcement financial reports: <a href="https://www.finanzen.net/aktien/brain_biotech-aktie">BRAIN Biotech</a> AG


 / Preliminary announcement on the disclosure of financial statements


<br/>


BRAIN Biotech AG: Preliminary  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-afr-brain-biotech-ag-preliminary-announcement-of-the-publication-of-financial-reports-according-to-articles-114-115-117-of-the-wphg-the-german-securities-act-15394863</guid></item></channel></rss>
